Clinical Trials List
Protocol NumberA928-CLN-001
Active
2023-04-01 - 2026-03-31
Phase I
Recruiting3
-
Trial Applicant
A2 HEALTHCARE TAIWAN CORPORATION
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Hsiang-Fong Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- 黃盈慈 Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 徐偉勛 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
38 participants
-
Global
38 participants
